Rapport special correspondent (and RA Capital Strategic Counsel) Sarah Reed sat down with RA Capital Head of Infectious Diseases Mario Barro, PhD, to discuss his circuitous journey from growing up in Havana, Cuba, to nuclear physics in the USSR, to becoming RA Capital’s head of infectious diseases and GIVAX’s chief executive.

Outgoing Forma Therapeutics CEO Frank Lee talks with Rapport about bringing a patient-centric mindset to a biotech steeped in science and Forma’s acquisition by Novo Nordisk.